Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05439291 · ClinicalTrials.gov registry record · NA

Comparing Operative vs Non Operative Treatment for Pilonidal Disease

A NA study of Pilonidal Disease, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
1
Study location

NCT05439291 is a NA study of Pilonidal Disease that is actively recruiting participants, run by Stanford University. The registered enrollment target is 400 participants, above the 69-participant average among 5 other Pilonidal Disease trials with a reported enrollment target (480% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05439291, a NA study of Pilonidal Disease, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

The goal is to evaluate whether surgical excision of the pilonidal disease is needed after resolution of the initial symptoms when the patient follows regular hair removal regimen such as laser epilation.

Conditions Studied

Interventions

  • PROCEDURE Regular Epilation Regimen
  • PROCEDURE Surgical excision

Study Locations (1)

California

  • Stanford University School of Medicine - Palo Alto

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2022-07-19
Est. Completion 2027-01
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT05439291

The ClinicalTrials.gov registry entry for NCT05439291 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 69-participant average among 5 other Pilonidal Disease trials with a reported enrollment target (480% higher). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pilonidal Disease appearing as the primary indexed condition, and to 2 interventions - of which Regular Epilation Regimen is the first listed.

NCT05439291 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05439291 about?

NCT05439291 is a clinical study titled "Comparing Operative vs Non Operative Treatment for Pilonidal Disease". The goal is to evaluate whether surgical excision of the pilonidal disease is needed after resolution of the initial symptoms when the patient follows regular hair removal regimen such as laser epilation.

What is the current status of trial NCT05439291?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2022-07-19. Estimated completion is 2027-01.

What conditions does trial NCT05439291 study?

This clinical trial studies the following conditions: Pilonidal Disease.

What interventions are being tested in trial NCT05439291?

The interventions under investigation include: Regular Epilation Regimen (PROCEDURE), Surgical excision (PROCEDURE).

Who is sponsoring clinical trial NCT05439291?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05439291 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pilonidal Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.